UCHL1 Antikörper (AA 1-223)
Kurzübersicht für UCHL1 Antikörper (AA 1-223) (ABIN306421)
Target
Alle UCHL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-223
-
Verwendungszweck
- Human PGP9.5/UCHL1 antibody
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant human PGP9.5 (1-223aa) purified from E. coli
-
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
- Recommended dilution 1:1000(W.B), Recommended dilution 1:100(IHC)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- UCHL1 (Ubiquitin Carboxyl-terminal Esterase L1 (Ubiquitin Thiolesterase) (UCHL1))
-
Andere Bezeichnung
- PGP9.5/UCHL1
-
Hintergrund
- PGP9. 5/UCH-L1 is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. PGP9. 5 is a component of the ubiquitin system, which has a fundamental role in regulating various biological activities. PGP9. 5 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.
-
NCBI Accession
- NP_004172
-
Pathways
- Feeding Behaviour
Target
-